Partner Headlines - ESRX

  1. GoPro, Other Earnings Trigger Wild Price Swings

    IBD
  2. EXPRESS SCRIPTS

    IBD
  3. Express Scripts Posts In-Line Q1 Earnings, Issues Strong Forecast

    Benzinga
  4. Stocks Stumble To Early Losses; IPG Photonics Jumps

    IBD
  5. Why CVS Health And McKesson May Be Good Stock Picks

    IBD
  6. UnitedHealth Profit Soars On ObamaCare, Optum

    IBD
  7. UnitedHealth Up After Topping Views, Raising Outlook

    IBD
  8. UnitedHealth Eyes Biggest Earnings Gain In Years

    IBD
  9. Pioneer Fundamental Growth Fund: Why Is It Revving Up?

    IBD
  10. Horizon Pharma Soars On Q4 Beat, Guidance Raise

    IBD
  11. Catamaran EPS Tops, But Stock Falls On Weak Guidance

    IBD
  12. 10 Stocks You Should Be Watching Today

    Benzinga
  13. EXPRESS SCRIPTS

    IBD
  14. UPDATE: Express Scripts Tops Q4 Expectations, Shares Rise After ...

    Benzinga
  15. Nasdaq Stretches Win Streak To 9 Days

    IBD
  16. Earnings Scheduled For February 23, 2015

    Benzinga
  17. Must Watch Stocks for Today

    Benzinga
  18. Stocks Cap Short Week With Gains; Salix Up On Buyout Hopes

    IBD
  19. Rolfe Adds One Company to Portfolio in Fourth Quarter

    GuruFocus
  20. Analyzing Needham Growth Fund's Pick: Express Scripts (ESRX)

    GuruFocus
  21. Analyzing Needham Growth Fund's Pick: CarMax (KMX)

    GuruFocus
  22. Rite Aid Stock Soars, Steps Up Competition With CVS

    IBD
  23. Gilead Sciences Offering Fresh Wave Of Competition To AbbVie's ...

    GuruFocus
  24. Thornburg Value Fund Q4 2014 Commentary

    GuruFocus
  25. Gilead Q4 Earnings Beat, But Price War Taking Toll

    IBD
  26. Baird Remains Buyers Of Gilead Before Earnings Release

    Benzinga
  27. Cramer Gives His Opinion On Whole Foods Market, Whiting Petroleum ...

    Benzinga
  28. AmerisourceBergen Hits New High On Earnings, Outlook

    IBD
  29. Has Gilead Sciences Been Able To Maintain Its Lead Run In The ...

    GuruFocus
  30. Gilead, AbbVie Hepatitis C Price Cuts Will Hit Sales

    IBD
  31. Why Drug Pricing Could Bring Volatility To The Biotech Sector ...

    Benzinga
  32. Aetna Sides With Gilead In Hepatitis C Drug Battle

    IBD
  33. What The Market's Reading: An Iraq Ramp-Up & Biotech Moves

    Benzinga
  34. Steven Romick Buys 7 US and International Stocks in Q4

    GuruFocus
  35. Express Scripts Eyes New Price War: Anti-PCSK9 Drugs

    IBD
  36. Cholesterol Drug Costs Eyed

    IBD
  37. AbbVie Inc.'s Forthcoming Future Looks Optimistic

    GuruFocus
  38. Amgen's Decline May Be Linked To Comments Of Express Script's ...

    Benzinga
  39. Biotechs Presenting At The J.P. Morgan Healthcare Conference: ...

    Benzinga
  40. AbbVie Stock Down After Guidance, Downgrade

    IBD
  41. Gilead Strikes Deal with CVS, Hits Back AbbVie

    GuruFocus
  42. Hepatitis Drugs Vie For Share

    IBD
  43. CVS Covering Gilead HCV Drugs, Countering AbbVie

    IBD
  44. Stocks Lose More Ground; Gilead Sciences Rises

    IBD
  45. CVS Picks Gilead Hep C Drugs As Price War Looms

    IBD
  46. Drug Distributor Reaps The Rewards Of Strategy Shift

    IBD
  47. Express Scripts Stock Dominated Q4; Which Funds Might've Won?

    Benzinga
  48. 5 Biotech Stocks With Big News Due In January

    IBD
  49. Stocks Hold Near Highs; LifeLock Breaks Out

    IBD
  50. Facebook Among IBD 50's Top 5 Earnings Kings In 2014

    IBD
  51. IBD 50: Biotechs Hammered, Then Find Support

    IBD
  52. First Pacific Advisors' Third-Quarter Investment in Yahoo! Increases ...

    GuruFocus
  53. Biotech Stocks Take A Beating, But Find Support

    IBD
  54. Stocks Score Small Gains; Virgin America Takes Flight

    IBD
  55. How Gilead And Johnson & Johnson's Tumble Affected These Hedge ...

    Benzinga
  56. Evercore ISI Analyst: 160,000 Patients Affected by AbbVie Hepatitis ...

    Benzinga
  57. Toys, Department Stores Rock, But Biotechs Tumble

    IBD
  58. Deutsche Bank Analyst Sees Gilead Sciences Vs. AbbVie 'Price ...

    Benzinga
  59. AbbVie Drug Displaces Gilead

    IBD
  60. Actavis, Valeant Largely Avoid Gilead's Hepatitis Dive

    IBD
  61. Express Scripts Picks AbbVie HCV Drugs Over Gilead

    IBD
  62. Express Scripts Knocks Gilead's Hepatitis C Drug in Favor of ...

    GuruFocus
  63. Bank Of America Downgrades Gilead Sciences, Sees Possible Pricing ...

    Benzinga
  64. Broad Indexes Little Changed; Facebook Breaks Out

    IBD
  65. Dow Outperforms While Nasdaq Holds Small Gain; Oil Weak

    IBD
  66. Express Scripts Picks AbbVie HCV Drugs Over Gilead

    IBD
  67. Mid-Morning Market Update: Markets Open Higher; Caesars Entertainment ...

    Benzinga
  68. Stocks Struggle To Hold Gains; Alaska Air, Spirit Up

    IBD
  69. Gilead Sciences Plummets Amid AbbVie Deal With Express Scripts

    Benzinga
  70. Stock Futures Point Higher; AbbVie Surges, Gilead Dives

    IBD
  71. AbbVie's Hep C Regimen OK'd, 12-Week Cost $83,319

    IBD
  72. How Can Drugmakers Handle New Pricing Pressures?

    IBD
  73. Are These Drugstore Retailers Good Investments?

    GuruFocus
  74. AmerisourceBergen a Key Player in the Pharma Industry

    GuruFocus
  75. Weekly 52-Week Highs Highlight: ITW, ESRX, TEVA, CHD, STI

    GuruFocus
  76. 5 Stock-Moving Medtech Events This December

    IBD
  77. Top 4 Stocks In The Health Care Plans Industry With The Highest ...

    Benzinga
  78. Surprisingly, Warren Buffett Buys These 8 Dividend Stocks

    GuruFocus
  79. Warren Buffett and CIOs Buy DirecTV, Charter Communications, ...

    GuruFocus
  80. Scour Mutual Fund Special Sections For Great Ideas

    IBD
  81. Buybacks-Driven Market: Engineered Too Far?

    YCharts
  82. #PreMarket Primer: Wednesday, October 29: Fed Likely To End Bond ...

    Benzinga
  83. Express Scripts Posts EPS In-line With Estimates

    Benzinga
  84. Stocks Tack On Gains; Centene Hits New High

    IBD
  85. AmerisourceBergen's Move To Go Big Is The Right Rx

    IBD
  86. 2015 Express Scripts Medicare Prescription Drug Plans Earn CMS ...

    Benzinga
  87. These 3 Upcoming IPOs Have Strong Investor Interest

    IBD
  88. IPO Calendar: HubSpot, Dave & Buster's Among 8 IPOs

    IBD
  89. 2 Mutual Funds Holding Hospital Stocks

    Benzinga
  90. UPDATE: Goldman Sachs Downgrades Express Scripts Holding Company

    Benzinga
  91. Benzinga's Top Downgrades

    Benzinga
  92. Goldman Sachs Downgrades Express Scripts To Neutral

    Benzinga
  93. Air Methods Navigates To Grow Medical Flight Business

    IBD
  94. Buyback ETF Slow-Footed: Better Ideas Here

    YCharts
  95. Without Its Tax Dodge, What’s Walgreen Worth?

    YCharts
  96. The Stocks Already in Correction Mode

    FoxBusiness
  97. Shares Of Express Scripts Up 5% Following Q2 Earnings

    Benzinga
  98. Quarterly “Beats”: Bah, Here Are Real Growers

    YCharts
  99. #PreMarket Primer: Tuesday, July 29: Russia Accused Of Violating ...

    Benzinga
  100. Earnings Scheduled For July 29, 2014

    Benzinga
Trading Center